Administered to prevent or treat conditions related to abnormal blood clotting, particularly when there is a high risk of thrombosis.
Often used in conjunction with PCI (angioplasty) to prevent blood clot formation during the procedure.
May be used to manage thrombocytopenia.
Uses:
Acute coronary syndromes (ACS).
Percutaneous coronary intervention (PCI).
Thrombocytopenia management.
Ischemic stroke.
Coronary artery bypass grafting (CABG).
Adjunctive treatment (high-risk patients).
Contraindications:
Known hypersensitivity or allergy to Aggribloc 5mg Injection or any of its components.
Active bleeding disorders or active bleeding episodes.
History of hemorrhagic stroke.
Major surgical procedures or significant trauma within the previous six weeks.
Kidney problems (dosage adjustment may be needed).
Known bleeding disorders such as hemophilia or von Willebrand disease.
Intracranial neoplasms (tumors) or aneurysms.
Elderly patients (use with caution).
Children (typically not used due to lack of established safety and efficacy).
Interaction with other drugs:
Inform the doctor about all medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Aggribloc 5mg Injection, reducing effectiveness or causing undesirable side effects.
Storage:
Stored at room temperature from 20°C to 25°C.
Keep away from moisture, heat, and light.
Do not freeze.
Keep away from children and pets.
Administration:
Typically administered intravenously (IV) in a healthcare setting.
Safety advices:
Pregnancy: consult your healthcare provider before use.
Breastfeeding: consult a healthcare provider.
Lungs: consult a healthcare provider if you have lung conditions.
Liver: individuals with liver dysfunction may have altered drug metabolism. Consult with a healthcare provider before using this medication.
Alcohol: alcohol can increase the risk of bleeding and interact with antiplatelet medications.
Driving: can impair driving ability. Consult a healthcare professional.
Side effects:
Serious: bleeding, thrombocytopenia, allergic reactions, low blood pressure, back pain or chest pain.
Common: bleeding at the injection site, nausea, headache, fever, pain or swelling at injection site, chest discomfort or tightness.
FAQ:
Q1: What should I do if I miss a dose of Aggribloc 5mg injection?
Since healthcare professionals administer Aggribloc 5mg injection, you should not miss a dose. Your medical team will manage the dosage and timing.
Q2: Is Aggribloc 5mg injection a blood thinner?
Aggribloc 5mg injection is not a blood thinner in the traditional sense. It is an antiplatelet medication that specifically inhibits platelet aggregation.
Q3: How often will I be monitored while on Aggribloc 5mg injection?
The frequency of monitoring can vary based on your specific medical condition and the duration of Aggribloc 5mg injection treatment. Your healthcare provider will determine the appropriate monitoring schedule.
Q4: Can I stop taking Aggribloc 5mg injection on my own?
You should never stop or adjust your tirofiban dosage without consulting your healthcare provider.
Q5: Are there any specific symptoms I should watch for related to Aggribloc 5mg injection side effects?
Be vigilant for signs of bleeding, such as nosebleeds, gum bleeding, blood in urine or stools, or excessive bruising. Watch for allergic reaction symptoms, including skin rash, swelling, and breathing difficulties.
Q6: Can Aggribloc 5mg injection cause low blood pressure?
Yes, Aggribloc 5mg injection can lower blood pressure in some individuals. If you already have low blood pressure, be cautious while using this medication.